Thomas Dunlap Named Independent Board Member at WaveFront Dynamics

WaveFront Dynamics Inc. (WDI) has welcomed Tom Dunlap to its Board of Directors.
 
“We are pleased to have Tom Dunlap join our Board of Directors. Tom brings a wealth in ophthalmic industry leadership experience and will fit well with our existing team,” WaveFront Dynamics’ Founder/CEO Dan Neal, Ph.D., said. “Tom has extensive experience in the ophthalmic and broader medical industries at both large, well-established companies and innovative startups.”
 
Dunlap is a senior executive with relevant expertise in commercialization and business strategy in many ophthalmic medical device businesses. His track record includes experience in entrepreneurial ventures and multinational companies. Dunlap has held executive management positions at Mynosys Cellular Devices (Centricity Vision), HOYA Surgical Optics, Allergan Medical Optics (J&J Vision), Bausch + Lomb, American Hospital Supply Corporation, Surgilase Inc., and Coherent, Inc. He brings to WDI’s board experience as an independent board member, non-executive director, and board chairman with private ophthalmic medical device companies.

Dunlap earned an MBA with honors from the University of Southern California in Los Angeles, and a bachelor of arts degree with honors from Ashland University in Ashland, Ohio.
 
“I am honored to be appointed to the Board of Directors and excited about WaveFront Dynamics’ future, especially the significant opportunity launching the WaveDȳn Vision Analyzer in the United States,” Dunlap said. “Dan has set the company on strong footing with a strong team, and a device that will expand treatment options by providing diagnostic data to enhance patients’ quality of vision. We are well-positioned to continue to deliver for patients and the physicians who serve them, while increasing value for our shareholders.”
 
Founded in 2019, WaveFront Dynamics is a privately held, commercial-stage medical device company that developed wavefront diagnostic technology for use in the vision care industry. The company is leveraging its WaveDȳn Vision Analyzer with dynamic measurements to yield new insights into assessing visual performance, advancing treatment options, and improving quality of life for the visually impaired.